ReviewTherapeutics and clinical risk management2016

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions.

Anna W Chalmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.